Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Supply of oncology generic medicines to NHS Scotland
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Accord Healthcare Ltd | 04596349 | ~£7,473,804 estimated from lot values | 1 lot Azacitidine Vials and Erlotinib Tablets | - |
| Bristol-Myers Squibb Pharmaceuticals | 02487574 | ~£5,655,912 estimated from lot values | 1 lot Dasatinib Tablets | LOBBYIST Hanover Communications International Limited (4 quarters) DGA Group UK Limited (3 quarters) FTI Consulting LLP (3 quarters) Ovid Consulting Ltd (2 quarters) |
| Dr Reddy's Laboratories (UK) Ltd | 01729064 | ~£7,473,804 estimated from lot values | 1 lot Azacitidine Vials and Erlotinib Tablets | - |
| Glenmark Pharmaceuticals Europe Ltd | 05040260 | ~£7,473,804 estimated from lot values | 1 lot Azacitidine Vials and Erlotinib Tablets | - |
| Novartis Pharmaceuticals UK Ltd | 00119006 | ~£1,748,789 estimated from lot values | 2 lots Octreotide Vials (Including Homecare) · Octreotide Vials (Excluding Homecare) | DONOR£3K across 2 donations To: Mr Nicholas Palmer LOBBYIST M&F Health (7 quarters) Sovereign Strategy Limited (1 quarter) MP LINK Mr David Lammy— Employment and earnings |
| Teva UK Limited | 00302461 | ~£1,748,789 estimated from lot values | 2 lots Octreotide Vials (Including Homecare) · Octreotide Vials (Excluding Homecare) | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£5,655,912 estimated from lot values | 1 lot Dasatinib Tablets | - |
This procurement was divided into 4 lots, each awarded separately. 15 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Octreotide Vials (Excluding Homecare) 240 days | £1,709,914 £1,470,521 initial term | 2 | Teva UK Limited Novartis Pharmaceuticals UK Ltd | complete |
| Lot 2 Octreotide Vials (Including Homecare) 240 days | £38,875 £33,432 initial term | 2 | Teva UK Limited Novartis Pharmaceuticals UK Ltd | complete |
| Lot 3 Dasatinib Tablets 240 days | £5,655,912 | 2 | Zentiva Pharma UK Ltd Bristol-Myers Squibb Pharmaceuticals | complete |
| Lot 4 Azacitidine Vials and Erlotinib Tablets 240 days | £7,473,804 £3,571,497 initial term | 9 | Dr Reddy's Laboratories (UK) Ltd Glenmark Pharmaceuticals Europe Ltd Accord Healthcare Ltd | complete |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £297,698,096 in 2,552 payments (over £25k) from Manchester University NHS Foundation Trust, Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT, Maidstone and Tunbridge Wells NHS Trust and 13 more public bodies (2010-04-28 to 2026-03-31).
Changes the buyer published to this notice after it first appeared.
Change of Lot Titles
Please note an amendment to the title of Lots 1 & 2 of this Notice. The amended Lot titles are:
Lot 1 - Octreotide Vials (Excluding Homecare)
Lot 2 - Octreotide Vials (Including Homecare)
This change is reflected in the ITT for this project.
Tender submission deadline moved back one month to noon on 14 May 2020 due to current strain on workload (both internally and externally) created by the COVID-19 situation. The framework start date will also be moved back by two months, making the new start date 1 August 2020.
Published by the buyer on this notice. Check the original notice — details change and are not updated here.